NEUROCRINE BIOSCIENCES INC Employee Count
The employee counts NEUROCRINE BIOSCIENCES INC states in its annual reports on SEC EDGAR, each as filed.
- 2023-12-31: Employees (as filed) 1,400; Filing 2024-02-09; Lease expense per employee $12,214.29.
- 2020-12-31: Employees (as filed) 845; Filing 2021-02-05; Lease expense per employee $11,952.66.
- 2019-12-31: Employees (as filed) 700; Filing 2020-02-07; Lease expense per employee $11,571.43.
- 2018-12-31: Employees (as filed) 585; Filing 2019-02-08; Lease expense per employee $11,794.87.
- Available history
- 2008-12-31 to 2023-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2023-12-31 | 1,400 full-time | 2024-02-09 | $12,214.29 operating |
| 2020-12-31 | 845 full-time | 2021-02-05 | $11,952.66 operating |
| 2019-12-31 | 700 full-time | 2020-02-07 | $11,571.43 operating |
| 2018-12-31 | 585 full-time | 2019-02-08 | $11,794.87 lease and rental expense |
| 2017-12-31 | 400 full-time | 2018-02-13 | $14,750.00 lease and rental expense |
| 2016-12-31 | 196 full-time | 2017-02-14 | $30,612.24 lease and rental expense |
| 2015-12-31 | 120 full-time | 2016-02-11 | $50,000.00 lease and rental expense |
| 2008-12-31 | 125 | 2009-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |